• MYLOD 5mg

    Mylod is used in the treatment of high blood pressure and chest pain (Angina).

  • MYLOD 2.5mg

    Mylod is used in the treatment of high blood pressure and chest pain (Angina).

  • MYLOD 10mg

    Mylod is used in the treatment of high blood pressure and chest pain (Angina).

  • CAMLO-5MG

    Camlo 5 MG Tablet is used to treat high blood pressure and other heart complications. The medicine should be taken in conjunction with a proper diet and regular exercise. It is also used in managing chest pain.

  • CAMLO-2.5MG

    • Camlo 2.5 MG Tablet is used to treat high blood pressure and other heart complications. The medicine should be taken in conjunction with a proper diet and regular exercise. It is also used in managing chest pain.

  • AMDOCAL-5MG

    • Inhibits movement of calcium ions across cell membrane in systemic and coronary vascular smooth muscle.
    • For Hypertension; chronic stable angina; vasospastic (Prinzmetal’s or variant) angina.
  • AMLOPRES 5MG

    Amlopres 5 Tablet belongs to a class of medicines known as a calcium channel blockers. It is used to treat high blood pressure (hypertension) and prevent angina (heart-related chest pain). It lowers blood pressure and reduces the workload of the heart which helps in preventing heart attacks and strokes.

  • ALMOPRES 2.5MG

    Amlopres 2.5 Tablet belongs to a class of medicines known as a calcium channel blockers. It is used to treat high blood pressure (hypertension) and prevent angina (heart-related chest pain). It lowers blood pressure and reduces the workload of the heart which helps in preventing heart attacks and strokes.

  • AMLOSUN 2.5mg

    Amlodipine
    Class: Calcium channel blocker

    Action:Inhibits movement of calcium ions across cell membrane in systemic and coronary vascular smooth muscle.
    Indications: Hypertension; chronic stable angina; vasospastic (Prinzmetal’s or variant) angina.

    Contraindications: Sick sinus syndrome; second- or third-degree atrioventricular (AV) block, except with a functioning pacemaker.
    Route/Dosage:
    ADULTS: PO 5 to 10 mg qd. ELDERLY: PO Initially 2.5 mg QD
    HEPATIC IMPAIRMENT PO Initially 2.5 mg qd
    Interactions:
    Beta-blockers: May cause increased adverse cardiac effects as a result of myocardial depression.
    Fentanyl: Severe hypotension or increased fluid volume requirements have occurred with similar drug.

    Lab Test Interferences well documented.

    Adverse Reactions

    CV: Palpitations; peripheral edema; syncope; tachycardia; bradycardia; arrhythmias; ventricular asystoles. CNS: Headache; dizziness; lightheadedness; fatigue; lethargy; somnolence. DERM: Dermatitis; rash; pruritus; urticaria. GI: Nausea; abdominal discomfort; cramps; dyspepsia. RESP: Shortness of breath; dyspnea; wheezing. OTHER: Flushing; sexual difficulties; muscle cramps, pain or inflammation.

    Precautions

    Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. CHF: Cautious use is required with this condition. Hepatic impairment: Cautious use is required.

    PATIENT CARE CONSIDERATIONS

    Administration/Storage

    Administer medication in morning.
    If patient has difficulty swallowing, crush tablets.
    Store in tightly closed container in cool location.
    Assessment/Interventions

    Obtain patient history, including drug history and any known allergies. Note any diabetes, liver disease, cardiac disease or sensitivity to calcium channel blockers.
    Monitor BP and pulse before administration.
    Review baseline ECG.
    Assess for signs of withdrawal syndrome. Abrupt withdrawal may cause increased frequency and duration of angina. Gradual tapering of dose is necessary.
    Assess patient for signs of CHF during therapy.
    If chest pain occurs, assess for location, intensity, duration, and radiation. Nitroglycerin preparations may be administered in conjunction with this medication.
    If drug is used with other calcium channel blockers or beta-blockers, observe for intensification of side effects.
    Withhold medication and notify physician if any of the following signs and symptoms occur: Sudden severe dyspnea; edema of hands and feet; changes in ECG (widened QRS, prolonged QT segments); pulse falls below 50 bpm.
    If the patient experiences chest pain not relieved by medication, continue medication and notify physician.
    OVERDOSAGE: SIGNS & SYMPTOMS Nausea, weakness, dizziness, drowsiness, confusion, slurred speech, hypotension, bradycardia, second- or third-degree AV block

    Patient/Family Education

    Teach patient how to monitor pulse before taking medication. Tell patient not to take medication if pulse if < 50 bpm and to call physician.
    Explain to patient how to monitor BP daily.
    Instruct patient not to stop taking this medication suddenly because doing so can cause chest pain and MI.
    Teach patient importance of good oral hygiene and frequent visits to dentist while taking medication.
    Inform patient that frequent follow-up appointments with physician are important to adjust medication dosage.
    Caution patient to avoid sudden position changes to prevent orthostatic hypotension.
    Instruct patient to avoid intake of alcoholic beverages or other CNS depressants.
    Advise patient that drug may cause drowsiness, and to use caution while driving or performing other tasks requiring mental alertness.
    Instruct patient not to take otc medications without consulting physician.

  • AMLOSUN 10mg

    Amlodipine
    Class: Calcium channel blocker

    Action:Inhibits movement of calcium ions across cell membrane in systemic and coronary vascular smooth muscle.
    Indications: Hypertension; chronic stable angina; vasospastic (Prinzmetal’s or variant) angina.

    Contraindications: Sick sinus syndrome; second- or third-degree atrioventricular (AV) block, except with a functioning pacemaker.
    Route/Dosage:
    ADULTS: PO 5 to 10 mg qd. ELDERLY: PO Initially 2.5 mg QD
    HEPATIC IMPAIRMENT PO Initially 2.5 mg qd
    Interactions:
    Beta-blockers: May cause increased adverse cardiac effects as a result of myocardial depression.
    Fentanyl: Severe hypotension or increased fluid volume requirements have occurred with similar drug.

    Lab Test Interferences well documented.

    Adverse Reactions

    CV: Palpitations; peripheral edema; syncope; tachycardia; bradycardia; arrhythmias; ventricular asystoles. CNS: Headache; dizziness; lightheadedness; fatigue; lethargy; somnolence. DERM: Dermatitis; rash; pruritus; urticaria. GI: Nausea; abdominal discomfort; cramps; dyspepsia. RESP: Shortness of breath; dyspnea; wheezing. OTHER: Flushing; sexual difficulties; muscle cramps, pain or inflammation.

    Precautions

    Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. CHF: Cautious use is required with this condition. Hepatic impairment: Cautious use is required.

    PATIENT CARE CONSIDERATIONS

    Administration/Storage

    Administer medication in morning.
    If patient has difficulty swallowing, crush tablets.
    Store in tightly closed container in cool location.
    Assessment/Interventions

    Obtain patient history, including drug history and any known allergies. Note any diabetes, liver disease, cardiac disease or sensitivity to calcium channel blockers.
    Monitor BP and pulse before administration.
    Review baseline ECG.
    Assess for signs of withdrawal syndrome. Abrupt withdrawal may cause increased frequency and duration of angina. Gradual tapering of dose is necessary.
    Assess patient for signs of CHF during therapy.
    If chest pain occurs, assess for location, intensity, duration, and radiation. Nitroglycerin preparations may be administered in conjunction with this medication.
    If drug is used with other calcium channel blockers or beta-blockers, observe for intensification of side effects.
    Withhold medication and notify physician if any of the following signs and symptoms occur: Sudden severe dyspnea; edema of hands and feet; changes in ECG (widened QRS, prolonged QT segments); pulse falls below 50 bpm.
    If the patient experiences chest pain not relieved by medication, continue medication and notify physician.
    OVERDOSAGE: SIGNS & SYMPTOMS Nausea, weakness, dizziness, drowsiness, confusion, slurred speech, hypotension, bradycardia, second- or third-degree AV block

    Patient/Family Education

    Teach patient how to monitor pulse before taking medication. Tell patient not to take medication if pulse if < 50 bpm and to call physician.
    Explain to patient how to monitor BP daily.
    Instruct patient not to stop taking this medication suddenly because doing so can cause chest pain and MI.
    Teach patient importance of good oral hygiene and frequent visits to dentist while taking medication.
    Inform patient that frequent follow-up appointments with physician are important to adjust medication dosage.
    Caution patient to avoid sudden position changes to prevent orthostatic hypotension.
    Instruct patient to avoid intake of alcoholic beverages or other CNS depressants.
    Advise patient that drug may cause drowsiness, and to use caution while driving or performing other tasks requiring mental alertness.
    Instruct patient not to take otc medications without consulting physician.

Main Menu